Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Pidala

Showing results (31-40 of 198) with videos related to

Pageof 20
Sort By:
Haematologica|July 28, 2011
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortalityJoseph Pidala, Jongphil Kim, Claudio Anasetti, et al.
Transplantation and Cellular Therapy|June 24, 2023
Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host DiseaseRebecca Gonzalez, Eric Gaskill, Maya Padilla, et al.
The Cochrane Database of Systematic Reviews|July 26, 2014
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantationMohamed Kharfan-Dabaja, Rahul Mhaskar, Tea Reljic, et al.
Immunotherapy|May 4, 2013
Efficacy of adoptive immunotherapy with donor lymphocyte infusion in relapsed lymphoid malignanciesNajla El-Jurdi, Tea Reljic, Ambuj Kumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 10, 2019
Carfilzomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Pilot Phase II TrialJoseph Pidala, Samantha Jaglowski, Annie Im, et al.
Palliative & Supportive Care|August 22, 2025
AutoFOCUS: A mindfulness-based intervention for caregivers of autologous hematopoietic stem cell transplant recipientsValerie Yepez, Min-Jeong Yang, Sierra Washington, et al.
Bone Marrow Transplantation|June 14, 2018
Hepatic veno-occlusive disease following sirolimus-based immune suppressionFarhad Khimani, George B McDonald, Howard M Shulman, et al.
Annals of Transplantation|December 25, 2010
Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host diseaseJoseph Pidala, Jongphil Kim, Jaime Roman-Diaz, et al.
Transplantation and Cellular Therapy|February 18, 2026
Longitudinal Study of Late Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: A Long-Term Follow-up Study from the Chronic Graft-Versus-Host Disease ConsortiumJoseph Pidala, Lynn Onstad, Paul Carpenter, et al.
Cancer Medicine|January 29, 2026
Trends in US Hematology/Oncology Physician Perceptions and Referral Practices for Hematopoietic Cell Transplant: A National Survey Conducted by NMDPAye Mon Thida, Ankita Shah, Kelley Frederick Steffens, et al.
Pageof 20

Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Haematologica|July 28, 2011
The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortalityJoseph Pidala, Jongphil Kim, Claudio Anasetti, et al.
Transplantation and Cellular Therapy|June 24, 2023
Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host DiseaseRebecca Gonzalez, Eric Gaskill, Maya Padilla, et al.
The Cochrane Database of Systematic Reviews|July 26, 2014
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantationMohamed Kharfan-Dabaja, Rahul Mhaskar, Tea Reljic, et al.
Immunotherapy|May 4, 2013
Efficacy of adoptive immunotherapy with donor lymphocyte infusion in relapsed lymphoid malignanciesNajla El-Jurdi, Tea Reljic, Ambuj Kumar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 10, 2019
Carfilzomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Pilot Phase II TrialJoseph Pidala, Samantha Jaglowski, Annie Im, et al.
Palliative & Supportive Care|August 22, 2025
AutoFOCUS: A mindfulness-based intervention for caregivers of autologous hematopoietic stem cell transplant recipientsValerie Yepez, Min-Jeong Yang, Sierra Washington, et al.
Bone Marrow Transplantation|June 14, 2018
Hepatic veno-occlusive disease following sirolimus-based immune suppressionFarhad Khimani, George B McDonald, Howard M Shulman, et al.
Annals of Transplantation|December 25, 2010
Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host diseaseJoseph Pidala, Jongphil Kim, Jaime Roman-Diaz, et al.
Transplantation and Cellular Therapy|February 18, 2026
Longitudinal Study of Late Acute and Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: A Long-Term Follow-up Study from the Chronic Graft-Versus-Host Disease ConsortiumJoseph Pidala, Lynn Onstad, Paul Carpenter, et al.
Cancer Medicine|January 29, 2026
Trends in US Hematology/Oncology Physician Perceptions and Referral Practices for Hematopoietic Cell Transplant: A National Survey Conducted by NMDPAye Mon Thida, Ankita Shah, Kelley Frederick Steffens, et al.
Pageof 20